Product Information

BETAMETHASONE DP 0.05% CRM is a generic product labeled by Zydus Pharmaceuticals (USA) Inc., priced at $0.4806 per GM under NDC 70710123301. Its NADAC has been published 377 times since Jun 5, 2019.

FDA first approved this application on Jan 11, 2019. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

BETAMETHASONE DP 0.05% CRM

Betamethasone dipropionate
$0.4806per GM

Strength

.5 mg/g

NDC

70710123301

Classification

Generic

Dosage Form

CREAM

Route

TOPICAL

Effective Date

8/19/2026

Active Ingredients

BETAMETHASONE DIPROPIONATE

Approval Type

Generic (ANDA)

FDA Application

ANDA208885

FDA Approved

1/11/2019

TE Code

AB

On Market Since

2/26/2019

Pharmacological Classes

Corticosteroid Hormone Receptor Agonists
Corticosteroid

Price Statistics

The NADAC for BETAMETHASONE DP 0.05% CRM has been published 377 times since Jun 5, 2019, and over the history we have for it it has declined 70.1%. The table below summarizes its recorded NADAC range and movement.

Current price$0.4806 per GM
All-time high$1.7423 (Jul 10, 2019)
All-time low$0.4125 (Nov 20, 2024)
52-week high$0.6898
52-week low$0.4806
Median price$0.7649
Average price$0.8682
Largest weekly change-36.0% (Jul 17, 2024)
Weeks tracked377
Tracking sinceJun 5, 2019

Price History

1W

-0.5%

1M

-0.5%

3M

-4.7%

6M

-5.4%

1Y

-30.3%

3Y

-34.6%

5Y

-47.2%

All

-70.1%

Generic Alternatives

The matcher finds 2 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 22% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Frequently asked questions

What is the NADAC price of BETAMETHASONE DP 0.05% CRM?

The current National Average Drug Acquisition Cost (NADAC) for BETAMETHASONE DP 0.05% CRM, manufactured by Zydus Pharmaceuticals (USA) Inc., is $0.4806 per GM (NDC 70710123301), effective Aug 19, 2026.

How has the price of BETAMETHASONE DP 0.05% CRM changed over time?

Over the history we have for it, the NADAC for BETAMETHASONE DP 0.05% CRM has declined 70.1%. It has been tracked across 377 weekly CMS publications since Jun 5, 2019.

What are the highest and lowest recorded NADAC prices for BETAMETHASONE DP 0.05% CRM?

Since Jun 5, 2019, the NADAC for BETAMETHASONE DP 0.05% CRM has ranged from a low of $0.4125 (Nov 20, 2024) to a high of $1.7423 (Jul 10, 2019), with a median of $0.7649 per GM.

Are there cheaper alternatives to BETAMETHASONE DP 0.05% CRM?

Yes. 2 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, BETAMETHASONE DP 0.05% CRM, is $0.3752 per GM — about 22% below BETAMETHASONE DP 0.05% CRM.

Who manufactures BETAMETHASONE DP 0.05% CRM?

BETAMETHASONE DP 0.05% CRM (NDC 70710123301) is labeled by Zydus Pharmaceuticals (USA) Inc., and CMS classifies it as a generic product.